Stocks · Healthcare · Medical - Instruments & Supplies
Merit Medical Systems, Inc. MMSI
$85.37 -0.91% Close, Oct 2, 2026 · NASDAQ · Market cap $5.10B
High qualityInexpensive vs sectorLow risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 14 quarters (average surprise over the last four: +14.1%).
- The shares trade at 35.3× trailing earnings, lower than 90% of the company's own readings over the past five years.
- The stock is in an uptrend: above its 200-day average for 49 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 47%
- EPS growth (TTM, YoY)Top 38%
- FCF growth (TTM, YoY)Bottom 31%
- Revenue growth, 3-year CAGRBottom 49%
- Revenue growth accelerationBottom 44%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 23%
- Gross marginBottom 33%
- Operating marginTop 21%
- Cash conversion (OCF / net income)Top 33%
- Accruals (lower is better)Bottom 41%
- Net debt / EBITDA (lower is better)Top 47%
- Interest coverTop 22%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 20%
- Free-cash-flow yieldTop 22%
- EBITDA / enterprise valueTop 18%
- Sales / enterprise valueTop 43%
- P/E vs own 5-year history (lower is better)Top 22%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 42%
- 6-month returnTop 35%
- 1-year return vs S&P 500Bottom 45%
- Distance from 52-week highTop 15%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 31%
- Consecutive EPS beatsTop 2%
- Share of analysts rating BuyTop 45%
- Upside to consensus price targetBottom 26%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 4%
- Maximum drawdown, 3 yearsTop 18%
- Beta vs S&P 500 (lower is better)Top 23%
- Net debt / EBITDA (lower is better)Top 47%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 11.2% | 10.3% | ↓ |
| EPS growth (YoY) | 13.2% | 22.8% | ↑ |
| Gross margin | 47.9% | 49.5% | ↑ |
| Operating margin | 12.0% | 12.8% | ↑ |
| FCF margin | 15.8% | 12.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 10.3% | 11.2% | ↓ | Top 47% |
| EPS growth (TTM, YoY) | 22.8% | 13.2% | ↑ | Top 38% |
| Gross margin | 49.5% | 47.9% | ↑ | Bottom 33% |
| Operating margin | 12.8% | 12.0% | ↑ | Top 21% |
| Net margin | 9.2% | 8.3% | ↑ | — |
| Free-cash-flow margin | 12.9% | 15.8% | ↓ | — |
| Return on invested capital | 5.8% | — | Top 23% | |
| Revenue growth, 3-year CAGR | 9.6% | — | Bottom 49% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.95×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +1.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.03×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 6.3×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.25%
- Shareholder yield
- -0.25%
- Share count change, 1 year
- -1.0%
- Share count change, 3-year CAGR
- +0.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 14
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +14.1%
- Average 2-day reaction, last 8
- +1.2%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $101.88
- Target vs current price
- +19.3%
- Analysts with a rating
- 15
- Share rating Buy or Strong Buy
- 80%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +24.1% | +3.1% | +7.8% | +12.0% | — |
| Apr 30, 2026 | +11.9% | +5.2% | -5.0% | -1.7% | +17.4% |
| Feb 24, 2026 | +8.3% | +1.0% | -6.3% | -16.5% | -21.9% |
| Oct 30, 2025 | +12.2% | +2.0% | +7.0% | +7.4% | +1.2% |
| Jul 30, 2025 | +17.4% | +0.1% | +2.0% | +7.5% | +2.0% |
| Apr 24, 2025 | +14.8% | +1.0% | +0.7% | +2.9% | -10.4% |
| Feb 25, 2025 | +13.4% | -1.4% | -0.5% | +1.1% | -4.5% |
| Oct 30, 2024 | +7.5% | -1.0% | +3.0% | +8.4% | +13.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $1.19 | $0.96 | +24.1% | $418.8M |
| Apr 30, 2026 | $0.94 | $0.84 | +11.9% | $381.9M |
| Feb 24, 2026 | $1.04 | $0.96 | +8.3% | $393.9M |
| Oct 30, 2025 | $0.92 | $0.82 | +12.2% | $384.2M |
| Jul 30, 2025 | $1.01 | $0.86 | +17.4% | $382.5M |
| Apr 24, 2025 | $0.86 | $0.75 | +14.8% | $355.4M |
| Feb 25, 2025 | $0.93 | $0.82 | +13.4% | $355.2M |
| Oct 30, 2024 | $0.86 | $0.80 | +7.5% | $339.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 35.3× | 47.1× | 10th | Top 20% |
| P/E (forward) | 19.8× | — | — | — |
| EV / EBITDA | 15.1× | — | — | Top 18% |
| EV / Sales | 3.46× | — | — | Top 43% |
| Free-cash-flow yield | 3.99% | — | — | Top 22% |
| Earnings yield | 2.83% | — | — | Top 20% |
P/E over the past five years
Range 29.5× – 136.5× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +4.0%
- Earnings per share growth (TTM)
- +22.8%
- Change in P/E multiple
- -18.2%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 49
- 50-day average slope (20 days)
- +7.1%
- 200-day average slope (20 days)
- +0.2%
- Distance from 50-day average
- -2.2%
- Distance from 200-day average
- +11.3%
- RSI (14)
- 42.2
- Relative volume
- 0.81×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 24.0%
- Volatility vs own 5-year history
- 30th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.64
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -8.4%
- Maximum drawdown, 3 years
- -45.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 30, 2025 | May 11, 2026 | -45.3% | 320 days | Not yet recovered |
| Sep 2, 2021 | Jul 12, 2022 | -29.4% | 214 days | 107 days (Dec 12, 2022) |
| Jun 7, 2023 | Oct 12, 2023 | -26.2% | 88 days | 178 days (Jun 28, 2024) |
| Feb 11, 2021 | Mar 4, 2021 | -13.8% | 14 days | 25 days (Apr 9, 2021) |
| Dec 13, 2022 | Mar 7, 2023 | -11.2% | 56 days | 20 days (Apr 4, 2023) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $5.10B
- P/E (TTM)
- 35.3
- EPS, diluted (TTM)
- $2.42
- Revenue (TTM)
- $1.58B
- 52-week range
- $59.74 – $94.75
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.07B | $1.15B | $1.26B | $1.36B | $1.51B |
| Gross profit | $485.3M | $519.1M | $583.9M | $643.3M | $736.9M |
| Operating income | $60.9M | $87.6M | $123.9M | $155.7M | $184.4M |
| Net income | $48.5M | $74.5M | $94.4M | $120.4M | $128.5M |
| EPS (diluted) | $0.84 | $1.29 | $1.62 | $2.03 | $2.13 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $339.8M | $355.2M | $354.3M | $382.0M | $384.3M | $394.2M | $381.9M | $418.8M |
| Net income | $28.4M | $27.9M | $30.1M | $32.6M | $27.8M | $38.0M | $41.0M | $38.8M |
| EPS (diluted) | $0.48 | $0.46 | $0.49 | $0.54 | $0.46 | $0.63 | $0.68 | $0.65 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $147.2M | $114.3M | $145.2M | $220.8M | $297.4M |
| Capital expenditure | -$27.9M | -$45.0M | -$36.7M | -$38.0M | -$84.8M |
| Free cash flow | $119.3M | $69.3M | $108.5M | $182.8M | $212.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $21.3M | $20.1M | $15.6M | $40.9M | $28.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $448.7M
- Total assets
- $2.86B
- Total liabilities
- $1.18B
- Total debt
- $820.1M
- Net debt
- $371.4M
- Shareholders’ equity
- $1.68B
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 3,934,838
- Days to cover
- 6.00
- Change vs previous report
- +8.8%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- May 6, 2011
- 5-for-4
- Dec 3, 2003
- 4-for-3
- Aug 15, 2003
- 4-for-3
- Apr 12, 2002
- 5-for-4
- Aug 28, 2001
- 5-for-4